Finance and venture capital for genetic engineering
In today's drug market the race is on more than ever for cures and treatments for common diseases. Some scientists believe that genetic research and engineering could be a key catylist for these treatments.
Many jurisdications including the UK and the US have very strict rules and regulations governing the practices in laboratories.
These ethical and moral issues can have the effect of slowing down progress in the field of genetic science and medical research. Some of the more aggressive drug companies are raising finance through venture capital and large commercial property mortgages against their property in the USA.
This is used to fund genetic research on remote islands and small countries without laws and ethical debates on genetic research. These jurisdictions offer well paid and unrestricted opportunity to recently qualified geneticists and other university graduates without issues from animal rights campaigners, religious leaders and green lobyists.
|
